Ulrike Felgenhauer

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Wastewater Treatment

Top Venues

The Journal of biological chemistry

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Lyudmila Shalamova, Ulrike Felgenhauer, Jochen Wilhelm, Andreas R Schaubmar, Kathrin Büttner, Andreas Schoen, Marek Widera, Sandra Ciesek, Friedemann Weber
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response. PNAS nexus 1 (2) (2022)
Lyudmila Shalamova, Ulrike Felgenhauer, Jochen Wilhelm, Andreas R Schaubmar, Kathrin Büttner, Andreas Schoen, Marek Widera, Sandra Ciesek, Friedemann Weber
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response. PNAS nexus 1 (2) (2022)
Namshik Han, Woochang Hwang, Konstantinos Tzelepis, Patrick Schmerer, Eliza Yankova, Méabh MacMahon, Winnie Lei, Nicholas M Katritsis, Anika Liu, Ulrike Felgenhauer, Alison Schuldt, Rebecca Harris, Kathryn Chapman, Frank McCaughan, Friedemann Weber, Tony Kouzarides
Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies. Science advances 7 (27) (2021)
Ulrike Felgenhauer, Andreas Schoen, Hans Henrik Gad, Rune Hartmann, Andreas R Schaubmar, Klaus Failing, Christian Drosten, Friedemann Weber
Inhibition of SARS-CoV-2 by type I and type III interferons. The Journal of biological chemistry 295 (41) (2020)